Evidence map›Paper›PMID 41595137›Full record

ArticleCancers2026

Cancer-Associated Fibroblast Heterogeneity Shapes Prognosis and Immune Landscapes in Head and Neck Squamous Cell Carcinoma.

Hideyuki Takahashi, Hiroyuki Hagiwara, Hiroe Tada, Miho Uchida, Toshiyuki Matsuyama, Kazuaki Chikamatsu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Current oncology (Toronto, Ont.) · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hideyuki TakahashiDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.ORCID 0000-0002-2465-3992
Hiroyuki HagiwaraDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.
Hiroe TadaDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.
Miho UchidaDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.
Toshiyuki MatsuyamaDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.ORCID 0000-0001-7043-3942
Kazuaki ChikamatsuDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan.ORCID 0000-0002-7739-0102

Funding

The Ministry of Education, Culture, Sports, Science, and Technology, Japan 20H03834The Ministry of Education, Culture, Sports, Science, and Technology, Japan 25K02785The Ministry of Education, Culture, Sports, Science, and Technology, Japan 25K12735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer-associated fibroblastshead and neck squamous cell carcinomaimmune landscapeinflammatory fibroblastsprognostic biomarkersrecursive partitioning analysissingle-cell RNA sequencingtumor microenvironment

Identifiers

PMID41595137
PMCPMC12838901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.